Medpace Holdings, Inc. Investing Cash Flow
Medpace Holdings, Inc. (MEDP) reported Investing Cash Flow of -$30.63 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-07-23
- Medpace Holdings, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$23.89M.
- Medpace Holdings, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$6.75M.
- Medpace Holdings, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$4.47M.
- Medpace Holdings, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$10.66M.
- Medpace Holdings, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$31.14M.
- Medpace Holdings, Inc. net cash provided by (used in) investing activities for fiscal 2024 was -$28.31M.
- Medpace Holdings, Inc. net cash provided by (used in) investing activities for fiscal 2023 was -$34.63M.
- Medpace Holdings, Inc. net cash provided by (used in) investing activities for fiscal 2022 was -$38.74M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$23.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | -$30.63M 10-Q · filed 2026-07-23 | -$35.11M derived: sum of 3 quarters · filed 2026-07-23 | -$45.77M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | -$6.75M 10-Q · filed 2026-04-23 | -$11.22M derived: sum of 2 quarters · filed 2026-04-23 | -$21.88M derived: sum of 3 quarters · filed 2026-04-23 | -$27.90M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | -$4.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$15.13M derived: sum of 2 quarters · filed 2026-02-10 | -$21.15M derived: sum of 3 quarters · filed 2026-07-23 | -$31.14M 10-K · filed 2026-02-10 |
| 2025-09-30 | -$10.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | -$16.68M derived: sum of 2 quarters · filed 2026-07-23 | -$26.67M 10-Q · filed 2025-10-23 | -$34.23M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | -$6.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | -$16.01M 10-Q · filed 2026-07-23 | -$23.57M derived: sum of 3 quarters · filed 2026-07-23 | -$34.05M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | -$9.99M 10-Q · filed 2026-04-23 | -$17.55M derived: sum of 2 quarters · filed 2026-04-23 | -$28.04M derived: sum of 3 quarters · filed 2026-04-23 | -$40.83M derived: sum of 4 quarters · filed 2026-04-23 |
| 2024-12-31 | -$7.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$18.05M derived: sum of 2 quarters · filed 2026-02-10 | -$30.84M derived: sum of 3 quarters · filed 2026-02-10 | -$28.31M 10-K · filed 2026-02-10 |
| 2024-09-30 | -$10.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | -$23.28M derived: sum of 2 quarters · filed 2025-10-23 | -$20.75M 10-Q · filed 2025-10-23 | -$28.74M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | -$12.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | -$10.26M 10-Q · filed 2025-07-22 | -$18.26M derived: sum of 3 quarters · filed 2026-02-10 | -$26.92M derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | $2.53M 10-Q · filed 2025-04-22 | -$5.47M derived: sum of 2 quarters · filed 2026-02-10 | -$14.13M derived: sum of 3 quarters · filed 2026-02-10 | -$22.60M derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | -$8.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | -$16.66M derived: sum of 2 quarters · filed 2026-02-10 | -$25.13M derived: sum of 3 quarters · filed 2026-02-10 | -$34.63M 10-K · filed 2026-02-10 |
| 2023-09-30 | -$8.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-22 | -$17.13M derived: sum of 2 quarters · filed 2024-10-22 | -$26.63M 10-Q · filed 2024-10-22 | -$35.85M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | -$8.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-23 | -$17.97M 10-Q · filed 2024-07-23 | -$27.19M derived: sum of 3 quarters · filed 2025-02-11 | -$34.38M derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | -$9.50M 10-Q · filed 2024-04-23 | -$18.72M derived: sum of 2 quarters · filed 2025-02-11 | -$25.91M derived: sum of 3 quarters · filed 2025-02-11 | -$37.04M derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-31 | -$9.22M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | -$16.41M derived: sum of 2 quarters · filed 2025-02-11 | -$27.53M derived: sum of 3 quarters · filed 2025-02-11 | -$38.74M 10-K · filed 2025-02-11 |
| 2022-09-30 | -$7.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-24 | -$18.31M derived: sum of 2 quarters · filed 2023-10-24 | -$29.52M 10-Q · filed 2023-10-24 | -$38.64M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | -$11.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | -$22.34M 10-Q · filed 2023-07-25 | -$31.45M derived: sum of 3 quarters · filed 2024-02-13 | -$38.05M derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | -$11.21M 10-Q · filed 2023-04-25 | -$20.32M derived: sum of 2 quarters · filed 2024-02-13 | -$26.92M derived: sum of 3 quarters · filed 2024-02-13 | -$32.92M derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | -$9.12M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | -$15.72M derived: sum of 2 quarters · filed 2024-02-13 | -$21.71M derived: sum of 3 quarters · filed 2024-02-13 | -$31.36M 10-K · filed 2024-02-13 |
| 2021-09-30 | -$6.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | -$12.60M derived: sum of 2 quarters · filed 2022-10-25 | -$22.25M 10-Q · filed 2022-10-25 | -$29.98M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | -$6.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-26 | -$15.65M 10-Q · filed 2022-07-26 | -$23.38M derived: sum of 3 quarters · filed 2023-02-14 | -$32.02M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | -$9.65M 10-Q · filed 2022-04-26 | -$17.39M derived: sum of 2 quarters · filed 2023-02-14 | -$26.03M derived: sum of 3 quarters · filed 2023-02-14 | -$35.34M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | -$7.73M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | -$16.38M derived: sum of 2 quarters · filed 2023-02-14 | -$25.69M derived: sum of 3 quarters · filed 2023-02-14 | -$31.21M 10-K · filed 2023-02-14 |
| 2020-09-30 | -$8.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-26 | -$17.96M derived: sum of 2 quarters · filed 2021-10-26 | -$23.48M 10-Q · filed 2021-10-26 | -$29.21M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | -$9.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | -$14.84M 10-Q · filed 2021-07-27 | -$20.57M derived: sum of 3 quarters · filed 2022-02-15 | -$26.70M derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | -$5.52M 10-Q · filed 2021-04-27 | -$11.25M derived: sum of 2 quarters · filed 2022-02-15 | -$17.38M derived: sum of 3 quarters · filed 2022-02-15 | -$20.82M derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | -$5.73M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | -$11.86M derived: sum of 2 quarters · filed 2022-02-15 | -$15.30M derived: sum of 3 quarters · filed 2022-02-15 | -$19.14M 10-K · filed 2022-02-15 |
| 2019-09-30 | -$6.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | -$9.57M derived: sum of 2 quarters · filed 2020-10-27 | -$13.41M 10-Q · filed 2020-10-27 | -$17.63M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | -$3.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | -$7.28M 10-Q · filed 2020-07-28 | -$11.49M derived: sum of 3 quarters · filed 2021-02-16 | -$14.28M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | -$3.84M 10-Q · filed 2020-04-29 | -$8.05M derived: sum of 2 quarters · filed 2021-02-16 | -$10.84M derived: sum of 3 quarters · filed 2021-02-16 | -$16.89M derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | -$4.21M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | -$7.00M derived: sum of 2 quarters · filed 2021-02-16 | -$13.04M derived: sum of 3 quarters · filed 2021-02-16 | -$16.97M 10-K · filed 2021-02-16 |
| 2018-09-30 | -$2.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | -$8.83M derived: sum of 2 quarters · filed 2019-10-29 | -$12.76M 10-Q · filed 2019-10-29 | -$16.14M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | -$6.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | -$9.97M 10-Q · filed 2019-07-30 | -$13.35M derived: sum of 3 quarters · filed 2020-02-25 | -$15.70M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | -$3.93M 10-Q · filed 2019-04-30 | -$7.31M derived: sum of 2 quarters · filed 2020-02-25 | -$9.66M derived: sum of 3 quarters · filed 2020-02-25 | |
| 2017-12-31 | -$3.38M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$5.73M derived: sum of 2 quarters · filed 2020-02-25 | -$12.24M 10-K · filed 2020-02-25 | |
| 2017-09-30 | -$2.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | -$8.85M 10-Q · filed 2018-10-30 | ||
| 2017-06-30 | -$6.50M 10-Q · filed 2018-07-31 | |||
| 2016-12-31 | -$13.42M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |